Asian Stocks Mixed as RBA Holds Rates, Oil Risks Rise 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Yen Stabilizes After Intervention Slide as Australian Dollar Hits Eight-Week High 
France Keeps Top Health Alert as Officials Brace for Another Heatwave 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Gold Price Hits Two-Month High as Investors Await US Inflation Data 
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger 
NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
US Judge Dismisses Gautam Adani Criminal Charges 
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
Researchers from the Korea Advanced Institute of Science and Technology (KAIST) have developed a wearable green organic light-emitting diode (OLED) with a 470-nanometer (nm) wavelength that can cure jaundice in infants.
The OLED provides sufficient power for jaundice treatment even at low voltage, durability for over 100 hours of operation, a low operating temperature of less than 35 Celsius degrees, and flexibility that can endure over 1,000 bends at a 2 mm radius of curvature.
The bilirubin level of the infants’ serum reaches 12 milligrams per decilitre (mg/dL) within three hours of being exposed to the OLED, indicating the completed treatment of jaundice.
Unlike existing light-emitting diode (LED)-based jaundice treatment devices currently used at hospitals, the OLED showed uniform and effective treatment functions.
